{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:54:27Z","timestamp":1781506467355,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U22A20328\/82572108\/82573538"],"award-info":[{"award-number":["U22A20328\/82572108\/82573538"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Joint Foundation for Science and Technology Innovation","award":["2024Y9418\/2024Y9420"],"award-info":[{"award-number":["2024Y9418\/2024Y9420"]}]},{"name":"Clinical Research Center for Infectious Diseases of Fujian Province","award":["2022Y2018"],"award-info":[{"award-number":["2022Y2018"]}]},{"name":"the Major Research Projects for Young and Middle-aged Talent of Fujian Provincial Health Commission","award":["2022ZQNZD014\/2024ZD01004"],"award-info":[{"award-number":["2022ZQNZD014\/2024ZD01004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune suppression is one of the primary obstacles in neoantigen immunotherapy because tumors can rapidly adapt by reducing MHC-I expression or antigen presentation. Here, we developed a novel immunotherapy strategy that combined vaccination of neoantigens with MICB \u03b13 antigen, by using bacterial outer membrane vesicles (OMVs) as a versatile vector and adjuvant. This approach aims to simultaneously induce a neoantigen-specific cellular immune response and an anti-MICB \u03b13 humoral immune response, to\u00a0enhance the recognition and killing of tumor cells by immune cells. This strategy significantly improves the infiltration of neoantigen-specific T cells and NK cells, and reverses immunosuppression across various preclinical models. Mechanistically, ILC1s characterized by high GZMA\/GZMB expression represent the primary subset accumulating within tumors and are responsible for enhancing antitumor immunity, which can induce Gasdermin D cleavage in tumor cells to\u00a0initiate tumor pyroptosis for a cascade of cancer-immunity cycle. Overall, this study demonstrated that combined neoantigens and shared MICB \u03b13 antigen for tumor vaccination enhances immune efficacy by eliciting ILC1s-mediated tumor pyroptosis and support the rationale and clinical translation for cancer immunotherapy.<\/jats:p>","DOI":"10.1038\/s44321-026-00424-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:48:41Z","timestamp":1776419321000},"page":"2098-2123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoantigens and shared MICB \u03b13 antigen dual-targeted vaccine generates potent antitumor immunity"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5129-2097","authenticated-orcid":false,"given":"Ruijing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5775-018X","authenticated-orcid":false,"given":"Honghao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-1843","authenticated-orcid":false,"given":"Liman","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0718-9128","authenticated-orcid":false,"given":"Jianhua","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-4981","authenticated-orcid":false,"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-8372","authenticated-orcid":false,"given":"Zhixiong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"424_CR1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14782-3","volume":"11","author":"U Bank","year":"2020","unstructured":"Bank U, Deiser K, Plaza-Sirvent C, Osbelt L, Witte A, Knop L, Labrenz R, Jansch R, Richter F, Biswas A et al (2020) c-FLIP is crucial for IL-7\/IL-15-dependent NKp46(+) ILC development and protection from intestinal inflammation in mice. Nat Commun 11:1056","journal-title":"Nat Commun"},{"key":"424_CR2","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1038\/s41591-025-03995-y","volume":"31","author":"M Baretti","year":"2025","unstructured":"Baretti M, Kirk AM, Ladle BH, Kamdar Z, Bendinelli KJ, Ho WJ, Adhikari S, Clark NA, Sundararaman B, Wang H et al (2025) A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial. Nat Med 31:4246\u20134255","journal-title":"Nat Med"},{"key":"424_CR3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","volume":"591","author":"S Biswas","year":"2021","unstructured":"Biswas S, Mandal G, Payne KK, Anadon CM, Gatenbee CD, Chaurio RA, Costich TL, Moran C, Harro CM, Rigolizzo KE et al (2021) IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591:464\u2013470","journal-title":"Nature"},{"key":"424_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.182.1.49","volume":"182","author":"P Boutet","year":"2009","unstructured":"Boutet P, Aguera-Gonzalez S, Atkinson S, Pennington CJ, Edwards DR, Murphy G, Reyburn HT, Vales-Gomez M (2009) Cutting edge: the metalloproteinase ADAM17\/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein. J Immunol 182:49\u201353","journal-title":"J Immunol"},{"key":"424_CR5","volume":"12","author":"Z Cai","year":"2025","unstructured":"Cai Z, Li Z, Zhong W, Lin F, Dong X, Ye H, Guo Y, Chen G, Yu X, Yu H et al (2025) Targeting mesothelin enhances personalized neoantigen vaccine induced antitumor immune response in orthotopic pancreatic cancer mouse models. Adv Sci 12:e2407976","journal-title":"Adv Sci"},{"key":"424_CR6","volume":"20","author":"Z Cai","year":"2021","unstructured":"Cai Z, Su X, Qiu L, Li Z, Li X, Dong X, Wei F, Zhou Y, Luo L, Chen G et al (2021) Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion. Mol Cancer 20:164","journal-title":"Mol Cancer"},{"key":"424_CR7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-11-3722","volume":"72","author":"JC Castle","year":"2012","unstructured":"Castle JC, Kreiter S, Diekmann J, Lower M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C et al (2012) Exploiting the mutanome for tumor vaccination. Cancer Res 72:1081\u20131091","journal-title":"Cancer Res"},{"key":"424_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1\u201310","journal-title":"Immunity"},{"key":"424_CR9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541:321\u2013330","journal-title":"Nature"},{"key":"424_CR10","doi-asserted-by":"crossref","first-page":"e004389","DOI":"10.1136\/jitc-2021-004389","volume":"10","author":"H Chen","year":"2022","unstructured":"Chen H, Li Z, Qiu L, Dong X, Chen G, Shi Y, Cai L, Liu W, Ye H, Zhou Y et al (2022) Personalized neoantigen vaccine combined with PD-1 blockade increases CD8(+) tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models. J Immunother Cancer 10:e004389","journal-title":"J Immunother Cancer"},{"key":"424_CR54","doi-asserted-by":"crossref","unstructured":"Cheng K, Zhao R, Li Y, Qi Y, Wang Y, Zhang Y, Qin H, Qin Y, Chen L, Li C, Liang J, Li Y, Xu J, Han X, Anderson GJ, Shi J, Ren L, Zhao X, Nie G (2021) Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat Commun 12:2041","DOI":"10.1038\/s41467-021-22308-8"},{"key":"424_CR11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41:374\u2013403","journal-title":"Cancer Cell"},{"key":"424_CR12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.aao0505","volume":"359","author":"L Ferrari de Andrade","year":"2018","unstructured":"Ferrari de Andrade L, Tay RE, Pan D, Luoma AM, Ito Y, Badrinath S, Tsoucas D, Franz B, May KF Jr, Harvey CJ et al (2018) Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity. Science 359:1537\u20131542","journal-title":"Science"},{"key":"424_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38:769\u2013781","journal-title":"Immunity"},{"key":"424_CR14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.addr.2017.05.003","volume":"114","author":"YMD Gnopo","year":"2017","unstructured":"Gnopo YMD, Watkins HC, Stevenson TC, DeLisa MP, Putnam D (2017) Designer outer membrane vesicles as immunomodulatory systems\u2014reprogramming bacteria for vaccine delivery. Adv Drug Deliv Rev 114:132\u2013142","journal-title":"Adv Drug Deliv Rev"},{"key":"424_CR15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419:734\u2013738","journal-title":"Nature"},{"key":"424_CR16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","volume":"28","author":"N Guerra","year":"2008","unstructured":"Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH (2008) NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28:571\u2013580","journal-title":"Immunity"},{"key":"424_CR17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099\u20131103","journal-title":"Nature"},{"key":"424_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature05768","volume":"447","author":"BK Kaiser","year":"2007","unstructured":"Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, Strong RK, Groh V, Spies T (2007) Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447:482\u2013486","journal-title":"Nature"},{"key":"424_CR19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41590-022-01213-2","volume":"23","author":"ER Kansler","year":"2022","unstructured":"Kansler ER, Dadi S, Krishna C, Nixon BG, Stamatiades EG, Liu M, Kuo F, Zhang J, Zhang X, Capistrano K et al (2022) Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies. Nat Immunol 23:904\u2013915","journal-title":"Nat Immunol"},{"key":"424_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","volume":"15","author":"M Kaparakis-Liaskos","year":"2015","unstructured":"Kaparakis-Liaskos M, Ferrero RL (2015) Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol 15:375\u2013387","journal-title":"Nat Rev Immunol"},{"key":"424_CR21","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim OY, Park HT, Dinh NTH, Choi SJ, Lee J, Kim JH, Lee SW, Gho YS (2017) Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response. Nat Commun 8:626","journal-title":"Nat Commun"},{"key":"424_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines5040034","volume":"5","author":"NN Kuzmich","year":"2017","unstructured":"Kuzmich NN, Sivak KV, Chubarev VN, Porozov YB, Savateeva-Lyubimova TN, Peri F (2017) TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines 5:34","journal-title":"Vaccines"},{"key":"424_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","volume":"21","author":"F Lang","year":"2022","unstructured":"Lang F, Schrors B, Lower M, Tureci O, Sahin U (2022) Identification of neoantigens for individualized therapeutic cancer vaccines. Nat Rev Drug Discov 21:261\u2013282","journal-title":"Nat Rev Drug Discov"},{"key":"424_CR24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1084\/jem.20061524","volume":"204","author":"A Le Floc\u2019h","year":"2007","unstructured":"Le Floc\u2019h A, Jalil A, Vergnon I, Le Maux Chansac B, Lazar V, Bismuth G, Chouaib S, Mami-Chouaib F (2007) Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med 204:559\u2013570","journal-title":"J Exp Med"},{"key":"424_CR25","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Zhang XQ, Ho W, Tang M, Li Z, Bu L, Xu X (2023) mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy. Nat Commun 14:4223","journal-title":"Nat Commun"},{"key":"424_CR26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/87757","volume":"2","author":"P Li","year":"2001","unstructured":"Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK (2001) Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2:443\u2013451","journal-title":"Nat Immunol"},{"key":"424_CR27","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s43018-020-0095-6","volume":"1","author":"Y Li","year":"2020","unstructured":"Li Y, Su Z, Zhao W, Zhang X, Momin N, Zhang C, Wittrup KD, Dong Y, Irvine DJ, Weiss R (2020) Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity. Nat Cancer 1:882\u2013893","journal-title":"Nat Cancer"},{"key":"424_CR28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00262-023-03598-x","volume":"73","author":"X Lin","year":"2024","unstructured":"Lin X, Tang S, Guo Y, Tang R, Li Z, Pan X, Chen G, Qiu L, Dong X, Zhang L et al (2024) Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer. Cancer Immunol Immunother 73:26","journal-title":"Cancer Immunol Immunother"},{"key":"424_CR29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nm.3773","volume":"21","author":"C Linnemann","year":"2015","unstructured":"Linnemann C, van Buuren MM, Bies L, Verdegaal EM, Schotte R, Calis JJ, Behjati S, Velds A, Hilkmann H, Atmioui DE et al (2015) High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat Med 21:81\u201385","journal-title":"Nat Med"},{"key":"424_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19420862.2018.1532767","volume":"11","author":"TN Lombana","year":"2019","unstructured":"Lombana TN, Matsumoto ML, Berkley AM, Toy E, Cook R, Gan Y, Du C, Schnier P, Sandoval W, Ye Z et al (2019) High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodies. MAbs 11:75\u201393","journal-title":"MAbs"},{"key":"424_CR31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","volume":"185","author":"RD Mazor","year":"2022","unstructured":"Mazor RD, Nathan N, Gilboa A, Stoler-Barak L, Moss L, Solomonov I, Hanuna A, Divinsky Y, Shmueli MD, Hezroni H et al (2022) Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. Cell 185:1208\u20131222.e1221","journal-title":"Cell"},{"key":"424_CR32","doi-asserted-by":"crossref","first-page":"e99008","DOI":"10.1371\/journal.pone.0099008","volume":"9","author":"A Meshcheryakova","year":"2014","unstructured":"Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D, Stremitzer S, Jensen-Jarolim E, Grunberger T et al (2014) B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. PLoS ONE 9:e99008","journal-title":"PLoS ONE"},{"key":"424_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","volume":"3","author":"L Oliveira-Nascimento","year":"2012","unstructured":"Oliveira-Nascimento L, Massari P, Wetzler LM (2012) The role of TLR2 in infection and immunity. Front Immunol 3:79","journal-title":"Front Immunol"},{"key":"424_CR34","volume":"18","author":"M Peng","year":"2019","unstructured":"Peng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, Guo C, Wu X, Li Y, Li X et al (2019) Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer 18:128","journal-title":"Mol Cancer"},{"key":"424_CR35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fimmu.2019.00774","volume":"10","author":"R Pio","year":"2019","unstructured":"Pio R, Ajona D, Ortiz-Espinosa S, Mantovani A, Lambris JD (2019) Complementing the cancer-immunity cycle. Front Immunol 10:774","journal-title":"Front Immunol"},{"key":"424_CR36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W, Jung H (2013) Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 31:413\u2013441","journal-title":"Annu Rev Immunol"},{"key":"424_CR37","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/bjc.2012.211","volume":"106","author":"CH Richards","year":"2012","unstructured":"Richards CH, Flegg KM, Roxburgh CS, Going JJ, Mohammed Z, Horgan PG, McMillan DC (2012) The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. Br J Cancer 106:2010\u20132015","journal-title":"Br J Cancer"},{"key":"424_CR38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","volume":"19","author":"PF Robbins","year":"2013","unstructured":"Robbins PF, Lu YC, El-Gamil M, Li YF, Gross C, Gartner J, Lin JC, Teer JK, Cliften P, Tycksen E et al (2013) Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat Med 19:747\u2013752","journal-title":"Nat Med"},{"key":"424_CR39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203454119","volume":"119","author":"N Rodriguez-Rodriguez","year":"2022","unstructured":"Rodriguez-Rodriguez N, Clark PA, Gogoi M, Ferreira ACF, Kerscher B, Crisp A, Jolin HE, Murphy JE, Sivasubramaniam M, Pedro L et al (2022) Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum. Proc Natl Acad Sci USA 119:e2203454119","journal-title":"Proc Natl Acad Sci USA"},{"key":"424_CR40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmb.2017.10.003","volume":"430","author":"AJ Russo","year":"2018","unstructured":"Russo AJ, Behl B, Banerjee I, Rathinam VAK (2018) Emerging insights into noncanonical inflammasome recognition of microbes. J Mol Biol 430:207\u2013216","journal-title":"J Mol Biol"},{"key":"424_CR41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","volume":"13","author":"C Schwechheimer","year":"2015","unstructured":"Schwechheimer C, Kuehn MJ (2015) Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 13:605\u2013619","journal-title":"Nat Rev Microbiol"},{"key":"424_CR42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168:707\u2013723","journal-title":"Cell"},{"key":"424_CR43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27:450\u2013461","journal-title":"Cancer Cell"},{"key":"424_CR44","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1158\/0008-5472.CAN-07-6768","volume":"68","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer I, Goehlsdorf D, Gieseke F, Weinschenk T, Wittenbrink M, Ludwig A, Stevanovic S, Rammensee HG, Steinle A (2008) Tumor-associated MICA is shed by ADAM proteases. Cancer Res 68:6368\u20136376","journal-title":"Cancer Res"},{"key":"424_CR45","doi-asserted-by":"crossref","first-page":"e20191062","DOI":"10.1084\/jem.20191062","volume":"217","author":"TA Waldmann","year":"2020","unstructured":"Waldmann TA, Miljkovic MD, Conlon KC (2020) Interleukin-15 (dys)regulation of lymphoid homeostasis: implications for therapy of autoimmunity and cancer. J Exp Med 217:e20191062","journal-title":"J Exp Med"},{"key":"424_CR46","volume":"6","author":"R Wang","year":"2025","unstructured":"Wang R, Wu J, Lin Y, Xiao Y, Yang B, Yao S, Pan T, Fu Z, Li S, Wang C et al (2025) An epitope-directed mRNA vaccine inhibits tumor metastasis through the blockade of MICA\/B alpha1\/2 shedding. Cell Rep Med 6:101981","journal-title":"Cell Rep Med"},{"key":"424_CR47","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bbrc.2009.07.062","volume":"387","author":"X Wang","year":"2009","unstructured":"Wang X, Lundgren AD, Singh P, Goodlett DR, Plymate SR, Wu JD (2009) An six-amino acid motif in the alpha3 domain of MICA is the cancer therapeutic target to inhibit shedding. Biochem Biophys Res Commun 387:476\u2013481","journal-title":"Biochem Biophys Res Commun"},{"key":"424_CR48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","volume":"8","author":"N Xie","year":"2023","unstructured":"Xie N, Shen G, Gao W, Huang Z, Huang C, Fu L (2023) Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther 8:9","journal-title":"Signal Transduct Target Ther"},{"key":"424_CR49","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","volume":"30","author":"M Yarchoan","year":"2024","unstructured":"Yarchoan M, Gane EJ, Marron TU, Perales-Linares R, Yan J, Cooch N, Shu DH, Fertig EJ, Kagohara LT, Bartha G et al (2024) Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial. Nat Med 30:1044\u20131053","journal-title":"Nat Med"},{"key":"424_CR50","doi-asserted-by":"crossref","first-page":"e1571388","DOI":"10.1080\/2162402X.2019.1571388","volume":"8","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Ma L, Goswami S, Ma J, Zheng B, Duan M, Liu L, Zhang L, Shi J, Dong L et al (2019) Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma. Oncoimmunology 8:e1571388","journal-title":"Oncoimmunology"},{"key":"424_CR51","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acs.nanolett.1c04977","volume":"22","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Wang Y, Zhao B, Chen H, Cai Z, Zheng Y, Zeng Y, Zhang D, Liu X (2022) Neoantigen immunotherapeutic-gel combined with TIM-3 blockade effectively restrains orthotopic hepatocellular carcinoma progression. Nano Lett 22:2048\u20132058","journal-title":"Nano Lett"},{"key":"424_CR52","doi-asserted-by":"crossref","first-page":"eaaz7548","DOI":"10.1126\/science.aaz7548","volume":"368","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, Wang Y, Li D, Liu W, Zhang Y et al (2020) Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science 368:eaaz7548","journal-title":"Science"},{"key":"424_CR53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-021-01164-5","volume":"14","author":"S Zhu","year":"2021","unstructured":"Zhu S, Zhang T, Zheng L, Liu H, Song W, Liu D, Li Z, Pan CX (2021) Combination strategies to maximize the benefits of cancer immunotherapy. J Hematol Oncol 14:156","journal-title":"J Hematol Oncol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00424-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00424-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:32:33Z","timestamp":1781505153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00424-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,15]]}},"alternative-id":["424"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00424-6","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}